Skadden has advised Theravance Biopharma. Kirkland & Ellis and Matheson have advised Zymeworks. Theravance Biopharma, Inc. and Zymeworks Inc. have entered into a definitive agreement under...
Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction
Augusta SpinCo Corporation Completes $3.5 Billion Senior Notes Offering Guaranteed by Waters Corporation
Paul Hastings LLP has advised the other underwriters. Kirkland & Ellis has advised Waters Corporation and its subsidiary Augusta SpinCo Corporation. Augusta SpinCo Corporation, a subsidiary...
Genius Sports Acquires Legend in $1.2 Billion Deal
Macfarlanes, Kirkland & Ellis and Carey Olsen have advised Genius Sports. Latham & Watkins and Herzog Fox & Neeman have advised Legend. Genius Sports, a leading...
CF Industries Completes $1 Billion Senior Notes Offering
Kirkland & Ellis has advised CF Industries, and Davis Polk has advised the joint book-running managers. CF Industries has completed an SEC-registered offering of $1 billion...
Bristol Myers Squibb Completes $7.5 Billion Tender Offer for Outstanding Notes
Kirkland & Ellis has advised Bristol Myers Squibb Company. Bristol Myers Squibb Company(NYSE: BMY), a global pharmaceutical company, has completed a concurrent tender offer valued at...
Bristol Myers Squibb Completes €5 Billion Euro Senior Notes Offering and $7.5 Billion Tender Offer
Kirkland & Ellis has advised Bristol Myers Squibb. Davis Polk & Wardwell has advised the underwriters. Bristol Myers Squibb has completed its inaugural €5 billion public...